Physician
Hill, Bradley
Hill, Bradley was paid $135K by Medicaid between Nov 2019 and Dec 2020, across 18 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoHILL, BRADLEY
ANTIOCH, TN 37013
ANTIOCH, TN 37013
33aNPI1114956687assigned 06/30/2006
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$135K
24GClaims4,682
24DCodes billed18
24AFirst – last monthNov 2019 – Dec 2020
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Tennessee
Rank by total paid#11 of 26
Median peer was paid$38K
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 219 | $7K | |
| 2020 | 4,463 | $128K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 1,054 | 946 | $36K |
| 64635 | 21% | 208 | 170 | $28K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 18% | 392 | 349 | $24K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 9.1% | 457 | 391 | $12K |
| 62323 | 8.1% | 126 | 116 | $11K | |
| 64636 | 7.6% | 208 | 169 | $10K | |
| 64493 | 2.6% | 144 | 107 | $3K | |
| 20610 | 2.1% | 143 | 113 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 256 | 229 | $3K |
| 64494 | 1.1% | 129 | 93 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 53 | 44 | $1K |
| 99406 | <1% | 179 | 169 | $1K |
6 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 27 | $192.68 |
| 81025 | <1% | 46 | $144.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $16.79 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 0% | 518 | $0.00 |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 182 | $0.00 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility | 0% | 518 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.